Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008, Article ID 683505, 10 pages
http://dx.doi.org/10.1155/2008/683505
Research Article

Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional in Vitro and in Vivo

1Austrianova Biotechnology GmbH, Veterinärplatz 1, A-1210 Vienna, Austria
2Children’s Cancer Research Institute, Kinderspitalgasse 6, A-1090 Vienna, Austria
3Research Institute of Virology and Biomedicine, University of Veterinary Medicine, Veterinärplatz 1, A-1210 Vienna, Austria
4Department of Pathobiology, University of Veterinary Medicine, Veterinärplatz 1, A-1210 Vienna, Austria
5Department of Pharmacology and Toxicology, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria

Received 1 October 2007; Accepted 14 December 2007

Academic Editor: Kanury V. S. Rao

Copyright © 2008 Reinhard Klein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Reinhard Klein, Bärbel Ruttkowski, Sonja Schwab, et al., “Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional in Vitro and in Vivo,” Journal of Biomedicine and Biotechnology, vol. 2008, Article ID 683505, 10 pages, 2008. https://doi.org/10.1155/2008/683505.